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Abstract
Background: Timely diagnosis and treatment of tuberculosis (TB) and HIV is important to reduce morbidity and mortality,
and break the cycle of ongoing transmission.
Methods: We performed an implementation research study to develop a model for systematic TB symptom screening and
HIV counseling and testing (HCT) for all adult clients at a primary care clinic and prospectively evaluate the 6-month
coverage and yield, and 18-month sustainability at a primary care clinic in Johannesburg, South Africa.
Results: During the first 6 months, 26,515 visits occurred among 12,078 adults. The proportion of adults aware of their HIV
status was 43.7% at the start of the first visit, increased to 84.6% at the end of the first visit, and to 90% at end of any visit
during the first 6 months. During these 6 months, 1042 clients were newly diagnosed with HIV. HIV prevalence was 22.9%
among those newly tested, and 58.9% among all adult clinic clients. High coverage of systematic HCT was sustained across
all 18 months. Coverage of systematic HIV-stratified TB symptom screening during first 6-months was also high (89.6%) but
only 35.0% of those symptomatic were screened by sputum. During these 6-months, 90 clients had a positive Xpert MTB/RIF
assay, corresponding to a TB prevalence of 0.4% among all 23,534 clients TB symptom-screened and 2.8% among the 3,284
clients with a positive TB symptom screen. The initial high coverage of TB symptom screening was not sustained, with
coverage of TB symptom screening dropping after the first six months to 70% and assessment by sputum dropping to 15%.
Conclusion: Routine, systematic HCT and HIV-stratified TB symptom screening is feasible at primary care level. Systematic
HCT doubled the proportion of clients with known HIV status. While HCT was sustainable, coverage of systematic TB
screening dropped significantly after the first 6 months of implementation.
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Introduction
The global burden of tuberculosis (TB) and human immuno-
deficiency virus (HIV) remains enormous. In 2012, there were an
estimated 35.3 million people living with HIV (PLWH), 2.3
million new HIV infections, 1.3 million AIDS deaths, 8.6 million
new cases of TB, and 1.3 million TB deaths, including 320,000
among PLWH [1,2]. In sub-Saharan Africa, there is a high
prevalence of undiagnosed TB in the community [3–5], many
people are unaware of their HIV status [6], and people often enter
care at advanced stages of disease [7], suggesting that the current
public health approach to diagnosis of TB and HIV is insufficient.
HIV counseling and testing (HCT) is predominantly delivered
through voluntary counseling and testing or provider-initiated
counseling and testing (PICT). Even though the World Health
Organization (WHO) recommends PICT for all people visiting a
health facility [8], PICT in health care facilities in high burden
countries is mainly targeted at individuals presenting for antenatal,
TB or STI care [9]. Alternative approaches such as testing
contacts of index cases, mobile testing, door-to-door testing, and
school-based testing can increase HIV case finding [10]. A similar
situation holds for TB, with suboptimal case finding using the
conventional approach of passive case finding among people
presenting to health facilities with symptoms suggestive of TB
[1,11]. In pursuit of a more active approach to TB case detection,
the WHO recommends intensified case finding among PLWH and
close contacts of individuals with infectious TB [12,13]. Mobile
TB screening, door-to-door screening, school-based programs,
and community sputum collection point programs have been
evaluated but are not routinely implemented [4,14,15].
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Despite high rates of missed TB and HIV case finding at health
facilities [16–19], few studies have evaluated the impact of
systematic TB symptom screening and HCT for all clients,
independent of the presence of risk factors. We aimed to develop a
primary care model for systematic TB and HIV screening for all
adults presenting to a primary care clinic. We evaluated the
model’s impact on knowledge of HIV status of clinic clients, HIV
and TB case finding, and assessed feasibility and sustainability at a
primary care clinic in Johannesburg, South Africa.
Methods
Ethics statement
The study was approved by the Institutional Review Board of
the University of North Carolina at Chapel Hill, USA, and the
Human Research Ethics Committee of the University of the
Witwatersrand, Johannesburg, South Africa. Clinic clients pro-
vided written consent for use of routine clinic data for research
purposes.
Study setting
The prospective implementation research study took place at
the Witkoppen Health and Welfare Centre (WHWC), a primary
care clinic serving Diepsloot, a densely populated informal
settlement community. Diepsloot, located in northern Johannes-
burg, is the 5th most deprived of the 420 geopolitical subdivisions
of Gauteng Province, South Africa [20].
Prior to the intervention, clinic clients were referred for HIV
counseling and testing either through self-request (voluntary HCT)
or by their provider (PICT) who targeted clients of antenatal care,
tuberculosis and sexually transmitted disease services. Symptom
screening for the presence of prolonged cough and weight loss was
initiated by the care provider at time of clinical evaluation, either
systematically among PLWH or as part of targeted clinical
assessment in others. Collection of sputum was performed if
requested by the nurse or doctor.
Development of a primary care model for integrated
routine screening for TB and HIV
Model development first involved meetings with the clinic
leadership to discuss preliminary findings [18], map current
patient flow, and identify possibilities for re-allocation of space and
distribution of new tasks. Meetings were then held to receive input
from clinic staff routinely involved in TB and HIV care and
treatment. To establish the final model, an iterative process was
implemented over a 12-month period using participatory quality
improvement methods. Once the final model was developed, the
TB symptom screening and HCT activities became routine clinic
activities and were no longer supported or monitored by research
staff.
Data collection
All data were collected as part of routine patient care. Data used
in the analysis were retrieved from paper-based medical files and
clinic registers, as well as electronic clinic records and laboratory
data. Clinic files of all adults (age $18 years) visiting the clinic
between 30 Jan 2012 and 27 July 2012 were reviewed and data
were collected on age, gender, pregnancy status, nationality,
employment, HIV status (known positive, negative test result in
prior 3 month period, unknown), outcome of HCT (positive,
negative, not done), CD4 count if newly diagnosed with HIV,
outcome of HIV-stratified TB symptom screening (positive,
negative, not done), collection of sputum (if positive symptom
screen), and Xpert MTB/RIF result.
To determine long-term sustainability, an additional file review
was performed for 162 clients randomly selected among those
visiting the clinic between January 28 to February 1, 2013 and 142
clients visiting the clinic during July 29 to August 2, 2013.
Statistical analysis
Characteristics of clinic clients are described using proportions
for categorical variables, and medians and interquartile ranges
(IRQ) for continuous variables. Detailed analysis of uptake and
results of HCT by prior HCT status was performed for all clinic
clients at the time of their first visit to the clinic during the six-
month period. To determine changes in weekly HIV and TB
screening outcomes of all visits (including repeat visits by some
clinic clients), linear regression modeling techniques were used,
incorporating an autoregressive error model to correct for the
time-series structure and autocorrelation. The model output
consists of a slope estimate (b) corresponding to an increase or
decrease per week during the 6-month period. For example, a b of
0.001 corresponds to an increase of 0.1% per week. Log-binomial
regression modeling was used to identify factors associated with
testing outcomes, with results presented as crude risk ratios (RR)
and 95% confidence intervals (95%CI).
Results
Model development for integrated systematic screening
for TB and HIV at primary care
During the iterative, 12-month participatory process, changes
were made to leverage existing space and staff, simplify patient
flow and reduce waiting times. Conditions agreed upon between
investigators and clinic staff were to: (1) integrate activities into
current clinic activities instead of creating separate screening
officers [21] (2) make HIV counseling part of routine care and
perform HIV testing in those with unknown HIV status unless the
client refuses, (3) have HCT precede TB screening to allow HIV-
stratified TB symptoms screening, and (4) perform HCT and TB
symptom screening during the time people wait to see a nurse or
clinician so that results are available at time of clinical evaluation.
Two TB symptom checklist stamps were developed to guide health
care workers in performing a rapid HIV-stratified TB screen. For
PLWH, symptoms suggestive of TB were cough, fever, night
sweats and loss of weight for any duration [12]. For HIV-negative
individuals, prolonged ($2 weeks) cough or fever, night sweats and
substantial weight loss were considered suggestive of active TB.
The final model involved staff across the spectrum of clinic
personnel. The administrative staff registering clinic clients at
presentation reviewed the client’s file to determine the individual’s
need for HCT. People who visited WHWC for the first time and
returning clients without documented HIV-infected status or a
documented HIV negative test performed more than three months
prior were judged in need of HCT and referred for group HIV
pretest counseling. Lay counselors performed HIV pretest
counseling in small groups throughout the morning prior to a
client’s clinical evaluation. At the end of the group session, people
were invited for one-on-one rapid HIV testing and post-test
counseling in a private setting. Upon completion of post-test
counseling, the counselor placed the appropriate TB symptom
screen stamp in the patient’s clinic file. It was then the task of the
clinic staff performing the routine assessment of vitals (weight,
temperature, blood pressure and pregnancy test) to complete the
information in the TB symptom screen stamp and to follow the
simple algorithm to determine which individuals had a positive TB
symptom screen. The same staff decided whether collection of a
sputum sample was indicated. Between July 1, 2011 and July 31,
Systematic TB and HIV Screening at Primary Care
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2012, Xpert MTB/RIF assay was performed at point-of-care, with
the goal to have the result ready by the time the patient was seen
by the nurse or doctor. After August 1, 2012, sputum samples were
transported to a centralized laboratory for analysis. If the first-line
clinic staff did not request a sputum sample, the nurse of doctor
could still request this upon completion of the history-taking and
clinical exam.
Clinic population
A total of 26,515 visits by 12,078 adults occurred at the clinic
during the 6-month period (30 Jan 2012 to 27 July 2012) after the
model was finalized as described above. The majority (69.5%) of
clinic clients were women, 16.8% of whom were pregnant
(Table 1). Ages of clients spanned the entire adult range, with a
median age of 35 years (IQR 28-43), and 13.7% being 50 years or
older. Almost one in three (32.3%) were not of South African
nationality, and half (51.7%) were unemployed.
Uptake of HIV counseling and testing
At time of arrival for the first clinic visit during the 6-month
period, 41.2% (95%CI: 40.3–42.0%) of the 12,078 adults were
known HIV positive, 2.5% (95%CI: 2.2–2.8%) had a documented
HIV negative test within the past 3 months, and 54.7% (95%CI:
53.8–55.6%) had an unknown HIV status (Table 2). Of those with
unknown HIV status, the vast majority (88.2%) had never been
tested for HIV at WHWC. Of those with unknown status, 74.8%
(95%CI: 73.6–75.9%) were tested during their first clinic visit. The
proportion tested was higher for those never previously tested at
WHWC (77.9%, 95% CI 76.8–79.0%) compared to those tested
more than 3 months ago (51.7%, 95% CI 48.2–55.2%). All except
one person with a prior negative HIV test had a repeat negative
HIV test. Among the 4537 tested for the first time at the clinic,
1041 new cases of HIV were detected (22.9%, 95% CI 21.7–
24.2%). The number needed to test to identify one new case of
HIV was 4.7 among all 4940 clients tested and 6.3 among all 6603
clients who received pretest counseling. By the end of the first
clinic visit during the 6-month period, 84.6% (95% CI 83.9–
85.2%) of all adult clients were aware of their HIV status, of which
58.9% were HIV positive. Failure to receive a documented HIV
status during the first clinic visit was not associated with gender
(RR 0.97, 95%CI: 0.93–1.02) but was higher among younger
clients (age,40 years, RR 1.25, 95% CI 1.19–1.30) and those with
foreign nationality (RR 1.10, 95% CI 1.05–1.15).
To assess sustainability, we assessed changes over time in the
proportion of clients knowledgeable of their HIV status by the end
of any clinic visit (i.e. first and repeat visits) (Figure 1). During the
6-month period, 90.0% (95%CI: 89.7–90.4%) of clients were
aware of their HIV status by the end of any visit. This proportion
did not change during the 6-month period (b= 0.000) and
remained similar 6 and 12 months later (92.6%, p = 0.27 and
86.0%, p = 0.12), suggesting long-term sustainability of routine
HCT.
While the HIV prevalence among newly-tested clients at any
visit decreased from an estimated 19.5% (95%CI: 10.5–28.3) to
16.4% (95%CI: 7.5–25.3) during the 6-month period (Figure 1),
HIV prevalence among clients newly tested when visiting the clinic
for the first time was 22.9% and increased from an estimated
19.5% (95%CI: 10.5–28.3) to 23.1% (95% CI: 11.4%–34.8%).
The median CD4 value at the time of a new HIV diagnosis was
260 cells/ml (IQR 136–412). Newly-diagnosed men had more
advanced disease compared to women (221 CD4 cells/ml, IQR:
94–352 among men vs. 295 cells/ml, IQR: 169–427 among
women, p,0.001).
Table 1. Characteristics of clients seeking care at a primary care clinic in Johannesburg, South Africa.
Overall Male Female
Number of clinic visits 26515 7831 18684
Number of individual clinic clients, n (%) 12078 3687 (30.5) 8391 (69.5)
Number of visits per client, median (range) 2 (1–11) 2 (1–11) 2 (1–10)
Age at first visit
Median (IQR) 35 (28–43) 36 (30–44) 34 (27–43)
18–29 years 3799 (31.5) 920 (24.2) 2879 (34.3)
30–39 years 4221 (35.0) 1375 (37.3) 2846 (33.9)
40–49 years 2407 (19.9) 876 (23.8) 1531 (18.3)
$50 years 1651 (13.7) 516 (14.0) 1135 (13.5)
Pregnancy status at first visit, n (%)*
Pregnant — — 1360 (16.8)
Not pregnant — — 6729 (83.2)
Nationality, n (%)#
Born in South Africa 8172 (67.8) 2395 (65.1) 5777 (68.9)
Born outside of South Africa 3890 (32.3) 1285 (34.9) 2605 (31.1)
Employment status at first visit, n (%)**
Employed 5827 (48.3) 1966 (53.4) 3861 (46.0)
Not employed 6246 (51.7) 1717 (46.6) 4529 (54.0)
IQR: interquartile range;
* pregnancy status missing in 302 (3.6%) of women;
#nationality missing in 16 (0.1%) individuals;
** employment status missing in 5 (0.0) individuals.
doi:10.1371/journal.pone.0105428.t001
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Uptake of HIV-stratified TB symptom screening
Information on completion of a TB symptom screen was
available for 26,279 clinic visits during the 6-month period
(Table 3). A TB symptom screen was performed at 89.6% (95%
CI 89.2–89.9%) of the visits (Figure 2). Of the 23,534 symptom
screens performed, 14.0% (95% CI 13.5–14.4%) were positive.
Among the 3284 visits with a positive TB symptom screen, a
sputum specimen was collected in 1150 (35.0%, 95%CI: 33.4–
36.7%), of which 90 (8.0%, 95% CI 6.5–9.7%) were positive for
Mycobacterium tuberculosis on Xpert MTB/RIF. Overall, 90 cases
of TB were detected, corresponding to a 7.8% case detection
among the 1150 cases screened by sputum, 2.7% case detection
rate among the 3284 clients with a positive symptom screen and
0.4% case detection among all 23534 clients screened for TB
symptoms.
There was no difference in TB symptom screening by gender
(RR 1.00. 95%CI: 0.99–1.01), but men were more likely to be
investigated by sputum (RR 1.45, 95%CI: 1.31–1.62) and were
twice as likely to test positive for M. tuberculosis (RR 2.24, 95%CI:
1.53–3.26). HIV-positive clients were more likely to be screened
for TB symptoms (94.4%) compared to HIV-negative clients
(84.3%); those with unknown HIV status were least likely to be
screened (70.6%). Case detection rate was similar among the three
groups (7.5%, 8.7% and 7.9% for HIV-positive, HIV-negative and
HIV-unknown, respectively). The number of clients needed to
symptom screen to identify one case of TB was 262 overall, 131 for
male clients, 448 for female clients, 317 for HIV infected clients,
Table 2. Uptake and results of HIV counseling and testing among 12,078 individuals visiting a primary care clinic in Johannesburg,
South Africa.
Overall Male Female
N* %* N* %* N* %*
HIV status at start of first visit
Known positive 4972 41.2 1481 40.2 3491 41.6
Known negative (test #3 m) 304 2.5 51 1.4 253 3.0
Unknown 6603 54.7 2103 57.0 4500 53.6
Prior tested (.3 m) 779 11.8 134 6.4 645 14.3
Not tested previously 5824 88.2 1969 93.6 3855 85.7
Clinic file not found 199 1.7 52 1.4 147 1.8
Outcome of HCT (among those with unknown HIV status)
Not tested 1663 25.2 592 28.2 1071 23.8
Tested 4940 74.8 1511 71.9 3429 76.2
All tested
HIV positive 1042 21.1 354 23.4 688 20.1
HIV negative 3898 78.9 1157 76.6 2741 79.9
Prior test (.3 m) negative
Tested 403 51.7 58 43.3 345 53.5
HIV positive 1 0.2 0 0.0 1 0.3
HIV negative 402 99.8 58 100.0 344 99.7
Not tested previously
Tested 4537 77.9 1453 73.8 3084 80.0
HIV positive 1041 22.9 354 24.4 687 22.3
HIV negative 3496 77.1 1099 75.6 2397 77.7
Initial CD4 count if newly diagnosed with HIV
Median (IQR) cells/ml 268 136–412 221 94–352 295 169–427
,50 cells/ml 87 8.3 46 13.0 41 6.0
50–199 cells/ml 262 25.1 109 30.8 153 22.2
200–350 cells/ml 283 27.2 92 26.0 191 27.8
.350 cells/ml 330 31.7 86 24.3 244 35.4
Missing 80 7.7 21 5.9 59 8.6
HIV status at end of clinic visit
Known 10216 84.6 3043 82.5 7173 85.5
Known positive 6014 58.9 1835 60.3 4179 58.3
Known negative 4202 41.1 1208 39.7 2994 41.7
Unknown 1862 15.4 644 17.5 1218 14.5
* N and % unless indicated otherwise the estimated proportion.
doi:10.1371/journal.pone.0105428.t002
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239 for HIV uninfected clients and 116 for clients with unknown
HIV status.
During the 6-month period, an increase over time was observed
for the uptake of TB symptom screening (from an estimated 84.7
(95%CI: 79.1–90.3%) to 93.5% (95%CI: 88.2–98.7%), b= 0.004)
and the proportion of TB suspects investigated by sputum (from an
estimated 19.9% (95%CI: 9.5–38.9%) to 49.8% (95%CI: 34.1–
65.4%), b= 0.012) (Figure 3). Associated with the increase in the
proportion of clients assessed by sputum, the proportion Xpert
MTB/RIF positive among those assessed by sputum decreased
(b= 20.003) from an estimated 12.6% (95%CI: 4.3–24.7%) to
5.3% (95%CI: 0.0–17.5%).
TB screening coverage was not sustained long-term, with
significantly lower proportion of clients screened for TB symptoms
6 and 12 months later (68.5% and 71.0%, respectively, p,0.001),
and significantly lower proportion of TB suspects assessed by
sputum 6 and 12 months later (15.3% and 13.6%, respectively,
p = 0.090).
Discussion
In this study, the first to our knowledge to implement and
evaluate a primary care model for integrated systematic HIV
counseling and testing and TB symptom screening, we achieved
high rates of TB symptom screening and HCT when implemented
for all adult clients at a primary care clinic in South Africa, with
89.6% being screened for TB symptoms and 84.6% of people
being aware of their HIV status by the end of their first clinic visit.
Six months of systematic screening for HIV and TB resulted in the
detection of 1042 cases of HIV, corresponding to a 22% HIV
prevalence among those with unknown status, and 90 new cases of
TB, corresponding to a 2.7% TB prevalence rate among those
with a positive symptom screen.
Missed opportunities for HIV testing at health facilities are
common, and only testing those perceived to be at high risk of
HIV can miss large numbers of PLWH [19]. Implementation of
routine HCT doubled the proportion of individuals knowledgeable
about their HIV status, from 43.7% at the start of the clients’ first
clinic visit to 84.6% by the end of the clinic visit. HCT uptake was
higher than that reported for other facility-based HCT approach-
es, and similar to the 80–85% uptake achieved in community-
based HCT programs [10].
HIV prevalence among those with unknown HIV status who
accepted testing was 19.5%, slightly higher but not statistically
different from the 16.1% estimated population HIV prevalence in
Gauteng Province in 2011 [22]. This is in contrast with results of a
meta-analysis, which found that the HIV positivity rate at facility-
based HCT was, on average, double that of community-based
HCT [10]. Despite high uptake, HCT did not result in high
proportions of diagnoses at early stages of disease, with only 31.7%
diagnosed at CD4 count .350 cells/ml, substantially lower than
the 40.2% estimate in a meta-analysis of individuals diagnosed
with CD4 count .350 through community-based HCT [10].
Taken together, these data suggest that systematic HIV testing at
facility levels can reach similar case finding rates as community-
based HCT but captures individuals at more advanced level of
disease progression.
Reports of missed opportunities for TB case finding at primary
care clinics suggest that TB case finding should not be limited to
passive case finding or PLWH [17]. We achieved high (89.6%)
coverage of HIV-stratified TB symptom screening of all clinic
clients, suggesting operational feasibility under programmatic
conditions. The proportion of individuals with positive symptom
screen assessed by sputum (35%) was lower than expected, in part
due to the frequent occurrence of unproductive cough. This is
similar to findings at primary care clinics in Botswana, where only
35.3% of those with a positive symptom screen were referred for
sputum smear microscopy or X-ray [23]. The TB case finding
yield was relatively low, with 90 cases detected, representing 2.8%
of the 3,284 clients with a positive TB symptom screen and 0.4%
Figure 1. Systematic HIV counseling and testing at primary care clinic in Johannesburg, South Africa: coverage, case detection and
sustainability over a 26-week period.
doi:10.1371/journal.pone.0105428.g001
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of the 23,534 clients screened. Operational feasibility but low yield
of systematic TB symptom screening was also observed in other
studies. In Botswana, 926 (8%) of 11,799 clinic clients had a
positive symptom screen, 327 (35.3%) were referred for examina-
tions (sputum smear microscopy or X-ray), and 19 (13.4% of those
tested, 0.2% of those screened) were diagnosed with TB [23]. In
outpatient departments of 32 hospitals in Swaziland [11], 14,998
(6%) of 251,867 clients screened positive and were tested using
Xpert, 1499 (10% of those tested, 0.6% of those screened) were
diagnosed with TB. In Afghanistan, 22,228 (2.5%) of 889,120
clinic attendees systematically screened for TB at 47 health
facilities were tested with smear microscopy of whom 1986 were
diagnosed with TB (8.9% of those tested, 0.2% of those screened)
[11].
In contrast to our findings of sustainability of systematic HCT,
the high coverage of systematic TB screening was not sustained
long term. The proportion of individuals symptom screened
dropped from 89.6% to about 70% and the proportion with
positive symptom screen assessed by sputum dropped from 35% to
about 15%. Several factors may have contributed to this
observation. First, whereas systematic HIV testing is part of a
South Africa national testing campaign, systematic TB symptom
Figure 3. Systematic TB symptom screening and assessment at primary care clinic in Johannesburg, South Africa: coverage, case
detection, and sustainability over a 26-week period.
doi:10.1371/journal.pone.0105428.g003
Figure 2. The TB screening cascade observed at 26,279 clinic visits at a primary care clinic in Johannesburg, South Africa. Black bars
represent screenings in all clinic clients, dark grey bars represent screenings in HIV-positive clinic clients, and light grey bars represent screenings in
HIV-negative clinic clients.
doi:10.1371/journal.pone.0105428.g002
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screening in all clinic clients is not recommended by the South
African Department of Health. Second, the number needed to
screen to detect one case is much higher for TB than HIV (262
versus 6), possibly resulting in a perception of higher effectiveness
and thus stronger motivation for the health care workers to test for
HIV compared to TB. Third, while Xpert MTB/RIF was
performed at point-of-care during the study period, samples were
sent to a centralized laboratory after the first 6 months. Lack of
immediate feedback on sputum results may further have decreased
the motivation of the clinic staff to collect sputum for evaluation.
The large sample size, pragmatic approach and the evaluation
under real-world conditions using non-research clinic staff to
perform all activities are important strengths of our study. The
interpretation of the findings however needs to take some
limitations into account. The study was a single-site observational
study without a control group. The impact of the intervention on
HIV and TB diagnoses could therefore not be estimated as the
proportion of new HIV and TB diagnoses that would have been
made under standard of care was not known. We also do not know
if missed diagnoses occurred among those who were not tested for
HIV, those with a negative TB symptom screen, and clients with a
positive symptom screen who were not assessed by sputum.
Inclusion of a historical control using routine clinic statistics could
provide some insights but would have inherent limitations due to
differences in time periods assessed and use of different data
collection standards. Finally, the available data did not allow us to
estimate cost effectiveness of the program, or to assess the impact
of the intervention on individual morbidity and mortality or
transmission of TB and HIV at population level.
Conclusion
To date, efforts to curb the TB/HIV epidemic have focused on
TB screening for PLWH and HCT for people diagnosed with
active TB. While outreach screening activities have been shown to
be effective, these programs require infrastructure development,
complicate linkage to care, and sustainability under programmatic
conditions of such programs can be hard to obtain. Improving TB
and HIV case finding at health facilities may be a more affordable
and sustainable first step to increase case finding in high burden
settings. Key features likely contributing to our program’s success
were full integration of TB symptom screening and HCT into
routine clinic activities, distribution of tasks across a range of clinic
personnel, and timing of HCT and TB symptom screening during
the time clinic clients waited to see a nurse or physician. Future
research is needed to explore the epidemiological and contextual
factors that improve the effectiveness of different tools and
approaches to systematic TB screening at primary care.
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